Clinical Trial 15139

Houston, TX 77062


Study Summary:

A phase 3 randomized, double-blind, multicenter, placebo controlled, combination study to evaluate the efficacy and safety of study medication and allopurinol compared to allopurinol alone in subjects with gout who have had an inadequate hypouricemic response to standard of care allopurinol.


Qualified Participants Must:

• Be 18-84 years of age
• Meet diagnosis of Gout
• Be taking 300mg of Allopurinol, for at least 8 weeks
• Have had at least 2 gout flares in the past 12 months


Qualified Participants May Receive:

Study medication and allopurinol, study related medical care and labs at no cost and compensation for time and travel.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.